ABG Acquisition I announced today it will not meet its deadline for closing a deal and will redeem shares, instead, effective Feb. 21.
Shares will cease trading on the Nasdaq at the close of business Feb. 17. An estimated per-share redemption price was not included in the announcement.
ABG I raised $131 million in an IPO two years ago to target the global healthcare industry, with a particular focus on the medical technology and biotechnology verticals. Read more.
